Correction: MUC1-C integrates activation of the IFN-γ pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer

Código QR

Correction: MUC1-C integrates activation of the IFN-γ pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer

Guardado en:

Detalles Bibliográficos
Formato:	article
Lenguaje:	EN
Publicado:	BMJ Publishing Group 2021
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/72b89d33bcec45c3bdcf6130a391f065
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

MUC1-C integrates activation of the IFN-γ pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer
por: Kwok-Kin Wong, et al.
Publicado: (2021)

Adipogenesis in triple-negative breast cancer is associated with unfavorable tumor immune microenvironment and with worse survival
por: Masanori Oshi, et al.
Publicado: (2021)

Comparison of the tumor immune microenvironment of primary hormone receptor-negative HER2-positive and triple negative breast cancer
por: Hanne Vos, et al.
Publicado: (2021)

Multiplexed imaging analysis of the tumor-immune microenvironment reveals predictors of outcome in triple-negative breast cancer
por: Aalok Patwa, et al.
Publicado: (2021)

An Immune-Related Gene Prognostic Index for Triple-Negative Breast Cancer Integrates Multiple Aspects of Tumor-Immune Microenvironment
por: Xiaowei Wang, et al.
Publicado: (2021)

Immunotherapy for triple-negative breast cancer: A molecular insight into the microenvironment, treatment, and resistance
por: Xupeng Bai, et al.
Publicado: (2021)

Akkermansia muciniphila mediates negative effects of IFNγ on glucose metabolism
por: Renee L. Greer, et al.
Publicado: (2016)

Bispecific antibody targeting TROP2xCD3 suppresses tumor growth of triple negative breast cancer
por: Huicheng Liu, et al.
Publicado: (2021)

Tumor heterogeneity and clonal cooperation influence the immune selection of IFN-γ-signaling mutant cancer cells
por: Jason B. Williams, et al.
Publicado: (2020)

IFN-γ mediates Paneth cell death via suppression of mTOR
por: Alessandra Araujo, et al.
Publicado: (2021)

Anti-MUC1 nano-aptamers for triple-negative breast cancer imaging by single-photon emission computed tomography in inducted animals: initial considerations
por: Santos do Carmo F, et al.
Publicado: (2016)

The homeobox protein VentX reverts immune suppression in the tumor microenvironment
por: Yi Le, et al.
Publicado: (2018)

TAK1 mediates microenvironment-triggered autocrine signals and promotes triple-negative breast cancer lung metastasis
por: Oihana Iriondo, et al.
Publicado: (2018)

Acquired IFNγ resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions
por: Antje Sucker, et al.
Publicado: (2017)

IFN-γ-dependent NK cell activation is essential to metastasis suppression by engineered Salmonella
por: Qiubin Lin, et al.
Publicado: (2021)

Systemic immune reaction in axillary lymph nodes adds to tumor-infiltrating lymphocytes in triple-negative breast cancer prognostication
por: Fangfang Liu, et al.
Publicado: (2021)

FUT8-mediated aberrant N-glycosylation of B7H3 suppresses the immune response in triple-negative breast cancer
por: Yun Huang, et al.
Publicado: (2021)

Deguelin action involves c-Met and EGFR signaling pathways in triple negative breast cancer cells.
por: Rajeshwari Mehta, et al.
Publicado: (2013)

Differential cytotoxic and radiosensitizing effects of silver nanoparticles on triple-negative breast cancer and non-triple-negative breast cells
por: Swanner J, et al.
Publicado: (2015)

IFNγ suppresses the expression of GFI1 and thereby inhibits Th2 cell proliferation.
por: Murshed H Sarkar, et al.
Publicado: (2021)

Immune Effect of Active Components of Traditional Chinese Medicine on Triple-Negative Breast Cancer
por: Wenjie Zhao, et al.
Publicado: (2021)

TEM8 marks neovasculogenic tumor-initiating cells in triple-negative breast cancer
por: Jiahui Xu, et al.
Publicado: (2021)

Styrene maleic acid-encapsulated RL71 micelles suppress tumor growth in a murine xenograft model of triple negative breast cancer
por: Martey O, et al.
Publicado: (2017)

A triple negative breast cancer: what it is not!
por: Katakkar SB
Publicado: (2012)

Triple negative breast cancer: an Indian perspective
por: Akhtar M, et al.
Publicado: (2015)

Molecular characteristics and metastasis predictor genes of triple-negative breast cancer: a clinical study of triple-negative breast carcinomas.
por: Wen-Hung Kuo, et al.
Publicado: (2012)

Immune microenvironment and intrinsic subtyping in hormone receptor-positive/HER2-negative breast cancer
por: Gaia Griguolo, et al.
Publicado: (2021)

The temporal mutational and immune tumour microenvironment remodelling of HER2-negative primary breast cancers
por: Leticia De Mattos-Arruda, et al.
Publicado: (2021)

LXR/RXR pathway signaling associated with triple-negative breast cancer in African American women
por: Torres-Luquis O, et al.
Publicado: (2018)

THE MAIN PARAMETERS OF CELLULAR IMMUNITY IN PATIENTS WITH TRIPLE-NEGATIVE BREAST CANCER: RELATIONSHIP WITH EFFICIENCY OF CHEMOTHERAPY
por: A. I. Chertkova, et al.
Publicado: (2018)

Quantitative proteomic landscape of metaplastic breast carcinoma pathological subtypes and their relationship to triple-negative tumors
por: Sabra I. Djomehri, et al.
Publicado: (2020)

Edelfosine nanoemulsions inhibit tumor growth of triple negative breast cancer in zebrafish xenograft model
por: Sofia M. Saraiva, et al.
Publicado: (2021)

NPM1 upregulates the transcription of PD-L1 and suppresses T cell activity in triple-negative breast cancer
por: Ge Qin, et al.
Publicado: (2020)

BRCA2 mutations and triple-negative breast cancer.
por: Peter Meyer, et al.
Publicado: (2012)

Triple-negative breast cancer: treatment challenges and solutions
por: Collignon J, et al.
Publicado: (2016)

Opportunities for metastatic triple negative breast cancer therapy
por: Inna P. Ganshina, et al.
Publicado: (2021)

Antiangiogenic therapy for breast cancer with triple negative phenotype
por: Inna P. Ganshina, et al.
Publicado: (2021)

Tumor microenvironment: the formation of the immune profile
por: E. K. Oleinik, et al.
Publicado: (2020)

IFN-γ selectively suppresses a subset of TLR4-activated genes and enhancers to potentiate macrophage activation
por: Kyuho Kang, et al.
Publicado: (2019)

DsbA-L deficiency in T cells promotes diet-induced thermogenesis through suppressing IFN-γ production
por: Haiyan Zhou, et al.
Publicado: (2021)